![A single center retrospective analysis of a protocol for high-dose methotrexate and leucovorin rescue administration - Zak Cerminara, Alison Duffy, Jennifer Nishioka, James Trovato, Steven Gilmore, 2019 A single center retrospective analysis of a protocol for high-dose methotrexate and leucovorin rescue administration - Zak Cerminara, Alison Duffy, Jennifer Nishioka, James Trovato, Steven Gilmore, 2019](https://journals.sagepub.com/cms/10.1177/1078155217729744/asset/images/large/10.1177_1078155217729744-fig1.jpeg)
A single center retrospective analysis of a protocol for high-dose methotrexate and leucovorin rescue administration - Zak Cerminara, Alison Duffy, Jennifer Nishioka, James Trovato, Steven Gilmore, 2019
![Elliot Tapper on X: "Hot take: Methotrexate does not cause liver fibrosis It's ok to be cautious (periodic fibroscan). It's ok to use MTX initiation as a trigger to look for fibrosis Elliot Tapper on X: "Hot take: Methotrexate does not cause liver fibrosis It's ok to be cautious (periodic fibroscan). It's ok to use MTX initiation as a trigger to look for fibrosis](https://pbs.twimg.com/media/FnkcjT4aIAEEunv.jpg)
Elliot Tapper on X: "Hot take: Methotrexate does not cause liver fibrosis It's ok to be cautious (periodic fibroscan). It's ok to use MTX initiation as a trigger to look for fibrosis
Methotrexate Monitoring in Dermatology— A Retrospective Cohort Study - JDDonline - Journal of Drugs in Dermatology
Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | PLOS ONE
![PDF] Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. | Semantic Scholar PDF] Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1e4f0a9a3a90ec9f13d64e26c9737cc6afd59a2f/4-Figure1-1.png)
PDF] Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. | Semantic Scholar
![A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities | Cancer Chemotherapy and Pharmacology A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities | Cancer Chemotherapy and Pharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00280-018-3733-2/MediaObjects/280_2018_3733_Fig1_HTML.png)
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities | Cancer Chemotherapy and Pharmacology
![PDF] Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | Semantic Scholar PDF] Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cbaa1feb117d9720c7872debf5f8ac470cd9f5f7/3-Table1-1.png)
PDF] Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | Semantic Scholar
![The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study - The Lancet Rheumatology The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/37f5c393-7186-4844-9ab7-cf8c782116fc/gr1_lrg.gif)
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study - The Lancet Rheumatology
![Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ](https://www.bmj.com/content/bmj/381/bmj-2022-074678/F2.medium.jpg)
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ
![Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ](https://www.bmj.com/content/bmj/381/bmj-2022-074678/F1.medium.jpg)
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ
![Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting | HTML | Acta Dermato-Venereologica Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/html-editor/table-pdf/big/4881/4881_3600.png)